Artelo Biosciences is a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signalling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. Co. is developing a G protein-coupled receptor targeting synthetic small molecule program, ART27.13, as a treatment for anorexia associated with cancer; ART26.12, which a small molecule inhibitor of Fatty Acid Binding Protein 5, for cancer therapeutic and anxiety-related disorder, including post-traumatic stress disorder; and ART12.11, a solid-state composition of cannabidiol. We show 13 historical shares outstanding datapoints in our ARTL shares outstanding history coverage, used to compute ARTL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ARTL market cap history over the course of time is important for investors
interested in comparing ARTL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ARTL versus a peer is one thing; comparing
ARTL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ARTL can fluctuate over the course of history.
With this page we aim to empower investors researching ARTL by allowing them to research the ARTL market cap history. |
Free ARTL Email Alerts:
Video: The Importance of Market Cap
